首页> The Lancet. Respiratory medicine> The course of action for effective anti-cytokine treatment in COVID-19.

The course of action for effective anti-cytokine treatment in COVID-19.

导出 LinkOut

翻译打印收藏纠错

第一作者： Giulio,Cavalli

第一单位： Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: cavalli.giulio@hsr.it.

作者： Giulio,Cavalli ^[1] ; Lorenzo,Dagna ^[2]

作者单位： Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: cavalli.giulio@hsr.it. ^[1] Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. ^[2]

医学主题词细胞因子类(Cytokines);人类(Humans);治疗结果(Treatment Outcome)

DOI 10.1016/S2213-2600(21)00405-7

PMID 34756179

发布时间 2022-03-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Lancet. Respiratory medicine

2021年9卷12期

1353-1354页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

The Lancet. Respiratory medicine

2021年9卷12期

1353-1354页

检索历史清除

The course of action for effective anti-cytokine treatment in COVID-19.

The Lancet. Respiratory medicine

相似文献

同项目论文

The Lancet. Respiratory medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The course of action for effective anti-cytokine treatment in COVID-19.

The Lancet. Respiratory medicine

相似文献

同项目论文

The Lancet. Respiratory medicine

相关期刊

检索历史清除